(Reuters) - The drug company had allegedly promoted Loprox -- typically used for fungal skin conditions such as athlete's foot -- among pediatricians as a treatment for diaper rash from about November 2001 through April 2004.
Loprox, known chemically as ciclopirox, is only approved by the U.S. Food and Drug Administration as a fungicide for patients over 10 years of age, the Justice department said.
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment